Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

BDKRB2 Antikörper (Intracellular)

BDKRB2 Reaktivität: Human WB, IHC, IF, IC Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN7042968
  • Target Alle BDKRB2 Antikörper anzeigen
    BDKRB2 (Bradykinin Receptor B2 (BDKRB2))
    Bindungsspezifität
    • 16
    • 5
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    AA 336-349, Intracellular
    Reaktivität
    • 33
    • 32
    • 20
    • 2
    Human
    Wirt
    • 45
    • 4
    Kaninchen
    Klonalität
    • 38
    • 11
    Polyklonal
    Konjugat
    • 14
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser BDKRB2 Antikörper ist unkonjugiert
    Applikation
    • 31
    • 17
    • 13
    • 13
    • 10
    • 4
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Immunochromatography (IC)
    Verwendungszweck
    A Rabbit Polyclonal Antibody to B2 Bradykinin Receptor
    Spezifität
    Intracellular, C-terminus
    Kreuzreaktivität
    Human, Maus, Ratte
    Homologie
    mouse - 11,Rat - 12,13 amino acid residues identical
    Produktmerkmale
    Anti-B2 Bradykinin Receptor (BDKRB2) Antibody (ABIN7042968, ABIN7043942 and ABIN7043943)) is a highly specific antibody directed against an epitope of the human protein. The antibody can be used in western blot, immunohistochemistry, and immunocytochemistry applications. It has been designed to recognize B2R from human, rat, and mouse samples.
    Aufreinigung
    Affinity purified on immobilized antigen.
    Immunogen

    Immunogen: Synthetic peptide

    Immunogen Sequence: GKRFRKKSWEVYQG(C), corresponding to amino acid residues 336-349 of human B2R

    Isotyp
    IgG
    Top Product
    Discover our top product BDKRB2 Primärantikörper
  • Applikationshinweise

    Antigen preadsorption control: 1 μg peptide per 1 μg antibody

    Application Dilutions Immunohistochemistry paraffin embedded sections ihc: N/A

    Application Dilutions Western blot wb: 1:1000

    Kommentare

    Cited Application: IHC

    Negative Control: BLP-BR012

    Blocking Peptide: BLP-BR012

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Rekonstitution
    0.2 mL double distilled water (DDW).
    Konzentration
    1 mg/mL
    Buffer
    PBS pH 7.4
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung

    Storage before reconstitution: The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C.

    Storage after reconstitution: The reconstituted solution can be stored at 4°C for up to 1 week. For longer periods, small aliquots should be stored at -20°C. Avoid multiple freezing and thawing. Centrifuge all antibody preparations before use (10000 x g 5 min).

  • Target
    BDKRB2 (Bradykinin Receptor B2 (BDKRB2))
    Andere Bezeichnung
    BDKRB2 (BDKRB2 Produkte)
    Hintergrund
    B2R, BKR2, B2BKR, BKRB2, Kinin B2, BRADYB2,Kinins are small peptides produced rapidly following tissue injury that serve as important modulators of inflammation and pain. In the periphery, the actions of kinins include vasodilatation, increased vascular permeability, stimulation of immune cells, and induction of pain. Kinins in the central nervous system (CNS) seem to initiate a similar cascade of events leading to neural tissue damage, as well as long lasting disturbances affecting blood-brain barrier function.1Kinins, such as Bradykinin (BK), Lys-BK, desArg9-BK, and Lys-desArg9-BK, exert their action via two distinct receptors: the B1 Bradykinin receptor (BKRB1) and the B2 Bradykinin receptor (BKRB2). BKRB2 is activated by BK and Lys-BK while desArg9-BK and Lys-desArg9-BK activate BKRB1.2 Activation of BKRB2 liberates mediators of vascular tone, fibrinolysis, and pain. BKRB2, which mediates most of the physiological effects of kinins, as well as BKRB1, represent potential therapeutic targets for treatment of inflammatory disorders and cardiovascular diseases.Both BKRB1 and BKRB2 are members of the seven-transmembrane domain, G protein-coupled receptor (GPCR) superfamily and share a common structure of seven putative transmembrane domains, an extracellular amino terminus, and a cytoplasmic carboxy terminus.BKRB2 is constitutively and widely expressed throughout the CNS and peripheral nervous system and on various cell types including endothelial cells, nerve fibers, leukocytes, and mast cells.3-5

    Alternative names: B2 Bradykinin Receptor (BDKRB2), B2R, BKR2, B2BKR, BKRB2, Kinin B2, BRADYB2
    Gen-ID
    624
    NCBI Accession
    NM_000623
    UniProt
    P30411
    Pathways
    ACE Inhibitor Pathway, Negative Regulation of intrinsic apoptotic Signaling
Sie sind hier:
Kundenservice